Longevity & AgingDouble-Hit Lymphoma's Hidden Origin Exposed by BCR Silencing Discovery
Researchers investigated the cellular origin and survival mechanisms of high-grade B-cell lymphomas harboring both MYC and BCL2 rearrangements (HGBCL-DH), commonly called 'double-hit' lymphomas. Using mouse models, patient samples, and molecular profiling, they discovered these tumors silence B-cell receptor (BCR) signaling—a pathway normally essential for B-cell survival—and instead rely on BCL2-driven anti-apoptotic programs and MYC-driven proliferation. Critically, the study identifies that these lymphomas arise from germinal center B cells that have lost BCR expression, making them uniquely dependent on BCL2 for survival. This work reveals therapeutic vulnerabilities including BCL2 inhibitors like venetoclax and highlights why standard BCR-targeting drugs fail in this lymphoma subtype.
